
Stanford research illustrates safer stem cell transplants for genetic disease
The innovative protocol could improve stem cell transplants and make them safer, enabling a broader disease population to take advantage of the benefits. New data from a Phase I clinical trial has demonstrated an innovative approach to reduce the toxicity …